Should serum voriconazole (Vori) levels be monitored in allogeneic hematopoietic stem cell transplant (HSCT) recipients?

被引：0
|
作者：
Trifilio, S
Ortiz, R
Pennick, G
Pi, J
Verma, A
Mehta, J
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2004年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
291
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [11] SERIAL MONITORING OF BLOOD CONCENTRATION OF VORICONAZOLE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Mori, T.
    Kato, J.
    Koda, Y.
    Kohashi, S.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S341 - S341
  • [12] CYTOKINE PATTERNS IN FAMILY CAREGIVERS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) RECIPIENTS
    Lee, Lena J.
    Ross, Alyson
    Son, Hyojin
    Flynn, Sharon
    Cox, Robert
    Yang, Li
    Wallen, Gwenyth R.
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S148 - S148
  • [13] Serum C-reactive protein levels affect the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients
    Yasu, Takeo
    Konuma, Takaaki
    Kato, Seiko
    Kurokawa, Yosuke
    Takahashi, Satoshi
    Tojo, Arinobu
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2731 - 2733
  • [14] Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant (HSCT) recipients: Significance in patients with abnormal hepatic function.
    Trifilio, S
    Ortiz, R
    Pennick, G
    Pi, J
    Verma, A
    Mehta, J
    BLOOD, 2003, 102 (11) : 441B - 442B
  • [15] Vaccination of allogeneic hematopoietic stem cell transplant recipients—what should be considered?
    Inken Hilgendorf
    Hildegard Greinix
    Jörg Halter
    Anita Lawitschka
    Daniel Wolff
    Annals of Hematology, 2017, 96 : 701 - 702
  • [16] EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes
    Law, Nancy
    Logan, Cathy
    Taplitz, Randy
    VIRUSES-BASEL, 2024, 16 (08):
  • [17] Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    J Brown
    B B Freeman
    Bone Marrow Transplantation, 2005, 36 : 177 - 177
  • [18] Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients
    T Mori
    Y Aisa
    J Kato
    Y Nakamura
    Y Ikeda
    S Okamoto
    Bone Marrow Transplantation, 2009, 44 : 371 - 374
  • [19] Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    Brown, J
    Freeman, BB
    BONE MARROW TRANSPLANTATION, 2005, 36 (02) : 177 - 177
  • [20] Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients
    Mori, T.
    Aisa, Y.
    Kato, J.
    Nakamura, Y.
    Ikeda, Y.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2009, 44 (06) : 371 - 374
12345